{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T11:40:20Z","timestamp":1724672420989},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,26]]},"DOI":"10.7759\/cureus.67800","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T10:40:58Z","timestamp":1724668858000},"source":"Crossref","is-referenced-by-count":0,"title":["Progressive Polycystic Kidney Disease in an Infant Girl With TSC2\/PKD1 Contiguous Gene Syndrome"],"prefix":"10.7759","author":[{"given":"Kazuhiko","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Hayashida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Otsubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yo","family":"Niida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumito","family":"Dateki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-014-3027-9","article-title":"Tuberous sclerosis complex: the past and the future","volume":"30","author":"De Waele L","year":"2015","unstructured":"De Waele L, Lagae L, Mekahli D. Tuberous sclerosis complex: the past and the future. Pediatr Nephrol. 2015, 30:1771-80. 10.1007\/s00467-014-3027-9","journal-title":"Pediatr Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2021.01.016","article-title":"Infantile spasms and early-onset progressive polycystic renal lesions associated with TSC2\/PKD1 contiguous gene deletion syndrome","volume":"86","author":"Matsubara Y","year":"2021","unstructured":"Matsubara Y, Akamine S, Chong PF, et al.. Infantile spasms and early-onset progressive polycystic renal lesions associated with TSC2\/PKD1 contiguous gene deletion syndrome. Seizure. 2021, 86:82-4. 10.1016\/j.seizure.2021.01.016","journal-title":"Seizure"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres VE","year":"2007","unstructured":"Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet. 2007, 369:1287-301. 10.1016\/S0140-6736(07)60601-1","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41439-020-0108-0","article-title":"Molecular diagnosis of an infant with TSC2\/PKD1 contiguous gene syndrome","volume":"7","author":"Osumi K","year":"2020","unstructured":"Osumi K, Suga K, Ono A, et al.. Molecular diagnosis of an infant with TSC2\/PKD1 contiguous gene syndrome. Hum Genome Var. 2020, 7:21. 10.1038\/s41439-020-0108-0","journal-title":"Hum Genome Var"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/ng1294-328","article-title":"Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome","volume":"8","author":"Brook-Carter PT","year":"1994","unstructured":"Brook-Carter PT, Peral B, Ward CJ, et al.. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome. Nat Genet. 1994, 8:328-32. 10.1038\/ng1294-328","journal-title":"Nat Genet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.33.6.480","article-title":"A cross sectional study of renal involvement in tuberous sclerosis","volume":"33","author":"Cook JA","year":"1996","unstructured":"Cook JA, Oliver K, Mueller RF, Sampson J. A cross sectional study of renal involvement in tuberous sclerosis. J Med Genet. 1996, 33:480-4. 10.1136\/jmg.33.6.480","journal-title":"J Med Genet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora SL","year":"2001","unstructured":"Dabora SL, Jozwiak S, Franz DN, et al.. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet. 2001, 68:64-80. 10.1086\/316951","journal-title":"Am J Hum Genet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1086\/514888","article-title":"Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene","volume":"61","author":"Sampson JR","year":"1997","unstructured":"Sampson JR, Maheshwar MM, Aspinwall R, et al.. Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet. 1997, 61:843-51. 10.1086\/514888","journal-title":"Am J Hum Genet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham JJ","year":"2006","unstructured":"Grantham JJ, Torres VE, Chapman AB, et al.. Volume progression in polycystic kidney disease. N Engl J Med. 2006, 354:2122-30. 10.1056\/NEJMoa054341","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.558","article-title":"Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months","volume":"75","author":"Kistler AD","year":"2009","unstructured":"Kistler AD, Poster D, Krauer F, et al.. Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months. Kidney Int. 2009, 75:235-41. 10.1038\/ki.2008.558","journal-title":"Kidney Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1990.330","article-title":"Renal structure and hypertension in autosomal dominant polycystic kidney disease","volume":"38","author":"Gabow PA","year":"1990","unstructured":"Gabow PA, Chapman AB, Johnson AM, et al.. Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int. 1990, 38:1177-80. 10.1038\/ki.1990.330","journal-title":"Kidney Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00077.x","article-title":"The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease","volume":"67","author":"Jafar TH","year":"2005","unstructured":"Jafar TH, Stark PC, Schmid CH, et al.. The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease. Kidney Int. 2005, 67:265-71. 10.1111\/j.1523-1755.2005.00077.x","journal-title":"Kidney Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres VE","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O, et al.. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012, 367:2407-18. 10.1056\/NEJMoa1205511","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfx079","article-title":"Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial","volume":"32","author":"Torres VE","year":"2017","unstructured":"Torres VE, Chapman AB, Devuyst O, et al.. Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial. Nephrol Dial Transplant. 2017, 32:1262. 10.1093\/ndt\/gfx079","journal-title":"Nephrol Dial Transplant"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres VE","year":"2017","unstructured":"Torres VE, Chapman AB, Devuyst O, et al.. Tolvaptan in later-stage autosomal dominant polycystic kidney disease. N Engl J Med. 2017, 377:1930-42. 10.1056\/NEJMoa1710030","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000000000022","article-title":"Tolvaptan for children and adolescents with autosomal dominant polycystic kidney disease: randomized controlled trial","volume":"18","author":"Mekahli D","year":"2023","unstructured":"Mekahli D, Guay-Woodford LM, Cadnapaphornchai MA, et al.. Tolvaptan for children and adolescents with autosomal dominant polycystic kidney disease: randomized controlled trial. Clin J Am Soc Nephrol. 2023, 18:36-46. 10.2215\/CJN.0000000000000022","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-024-00854-6","article-title":"A child with TSC2\/PKD1 contiguous gene deletion syndrome successfully treated with tolvaptan for rapidly enlarging renal cysts","author":"Muroga C","year":"2024","unstructured":"Muroga C, Yokoyama H, Kinoshita R, et al.. A child with TSC2\/PKD1 contiguous gene deletion syndrome successfully treated with tolvaptan for rapidly enlarging renal cysts. CEN Case Rep. 2024, 10.1007\/s13730-024-00854-6","journal-title":"CEN Case Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000000000028","article-title":"Tolvaptan for autosomal dominant polycystic kidney disease in children: why, who, and when?","volume":"18","author":"Hartung EA","year":"2023","unstructured":"Hartung EA. Tolvaptan for autosomal dominant polycystic kidney disease in children: why, who, and when?. Clin J Am Soc Nephrol. 2023, 18:11-3. 10.2215\/CJN.0000000000000028","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/275934-progressive-polycystic-kidney-disease-in-an-infant-girl-with-tsc2pkd1-contiguous-gene-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T10:41:01Z","timestamp":1724668861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/275934-progressive-polycystic-kidney-disease-in-an-infant-girl-with-tsc2pkd1-contiguous-gene-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.67800","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,26]]}}}